Evidence map›Paper›PMID 29881711›Full record

ArticleAvicenna journal of phytomedicine

Protective effect of

Fatemeh Namazi, Tahoora Shomali, Pouya Taghikhani, Saied Nazifi

Abstract read
In one paragraph

Article in Avicenna journal of phytomedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Antioxidants (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fatemeh NamaziDepartment of Pathobiology, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
Tahoora ShomaliDivision of Pharmacology and Toxicology, Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
Pouya TaghikhaniDivision of Pharmacology and Toxicology, Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
Saied NazifiDepartment of Clinical Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveFinding compounds that could be used for prevention of atherosclerosis (AS) is highly desired. The present study evaluated the protective effects of MATERIALS AND

methodsIn this study, 40 male adult Sprauge-Dawley rats were randomly allocated to 4 equal groups and treated as follows for 9 consecutive weeks: (1) Normal control (NC; normal rats that were fed with a basic diet); (2) Atherosclerotic rats (AT; which received no particular treatment); (3) Atherosclerotic rats that received 100 mg/kg/day ethanolic extract of UD orally and (4) Atherosclerotic rats that received simvastatin 4 mg/kg/day orally. Atherosclerosis was induced by a high-fat diet accompanied by propylthiouracil and vitamin D3.

resultsMarked hypercholesterolemia and significant increase in LDL-C/HDL-C ratio were observed in rats of AT group. Administration of UD significantly reduced these parameters as compared to AT group (p<0.05 for all cases). In histopathological evaluations of the aortic arch, AT rats showed atherosclerotic lesions, which were markedly ameliorated in rats treated with UD or simvastatin. Simvastatin and UD significantly reduced medial (p<0.05) but not intimal thickness. Increased level of malondialdehyde (MDA) and reduced total antioxidant capacity (TAC) were observed in the aortic arch of AT rats (p<0.05 for all cases). In contrast with simvastatin, UD extract had no significant effect on these parameters.

conclusionEthanolic extract of UD prevents establishment of atherosclerotic lesions in rat aorta, which is associated with positive effects on serum lipid profile without significantly affecting antioxidant status.

Indexed as

AtherosclerosisHistopathologyOxidative stressRatStinging nettleUrtica dioica

Identifiers

PMID29881711
PMCPMC5987440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.